Article Text

Download PDFPDF
Case report
Neuromyelitis optica spectrum disorder and active tuberculosis
  1. James Kerr Grieve1,
  2. Scott Day2,
  3. David Connell3 and
  4. Jonathan O'Riordan1
  1. 1Department of Neurology, University of Dundee, Dundee, UK
  2. 2General Medicine, Ninewells Hospital, Dundee, Tayside, UK
  3. 3Respiratory, Ninewells Hospital, Dundee, Tayside, UK
  1. Correspondence to Dr Jonathan O'Riordan; joriordan{at}nhs.net

Abstract

Tuberculosis is on the rise again. It brings with it potential for neurological involvement both as a direct infection and as a parainfectious process. Accordingly we report the development of neurological problems affecting a 48-year-old patient’s vision and sensation while being treated for active tuberculosis. At its nadir her vision deteriorated to nil perception of light and she had a sensory level to T10. Neuromyelitis optica spectrum disorder was diagnosed. We discuss our management strategy with neuromodulation in the context of active tuberculosis infection.

  • infection (neurology)
  • TB and other respiratory infections
  • neuroopthalmology

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Twitter @Dr Jonathan O'Riordan

  • Contributors JKG has contributed to the clinical management of the patient, the design of the case report; has seen the initial drafts and made contributions to its contents; has seen the final submission. SD has contributed to the clinical management of the patient, the design of the case report; has seen the initial drafts and made contributions to its contents; has seen the final submission. DC has contributed to the clinical management of the patient, the design of the case report; has seen the initial drafts and made contributions to its contents; has seen the final submission. JO’R has contributed to the clinical management of the patient, the design of the case report; has obtained consent; has obtained images/figures; has seen the initial drafts and made contributions to its contents; has seen the final submission.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.